/binding-characterization

name: binding-characterization
description: >
  Guidance for SPR and BLI binding characterization experiments. Use when:
  (1) Planning binding kinetics experiments,
  (2) Troubleshooting poor/no binding signal,
  (3) Interpreting kinetic data artifacts,
  (4) Choosing between SPR vs BLI platforms.
license: MIT
category: experimental
tags: [binding, spr, bli, validation]

Binding Characterization: SPR and BLI

SPR vs BLI Decision Matrix

| Factor | Choose SPR | Choose BLI | |--------|------------|------------| | **Sensitivity** | Small molecules, fragments (<500 Da) | Large complexes, antibodies | | **Throughput** | Low-medium (serial) | High (96-well parallel) | | **Sample purity** | Required (clogs fluidics) | Tolerates crude lysates | | **Kinetic resolution** | Higher (better for fast kinetics) | Lower | | **Mass transport** | More sensitive (may distort kon) | Less sensitive | | **Maintenance** | High (fluidics system) | Low (dip-and-read) | | **Sample consumption** | Higher (continuous flow) | Lower | | **Cost per experiment** | Lower chip cost, higher run cost | Higher tip cost, lower run cost |

Key differences

SPR (Surface Plasmon Resonance)

• **Mechanism**: Detects refractive index changes at gold surface
• **Surface**: Gold chip with dextran matrix (CM5, CM7, etc.)
• **Flow**: Continuous microfluidics
• **Best for**: Small molecules, high-affinity, precise kon/koff

BLI (Biolayer Interferometry)

• **Mechanism**: Measures optical interference pattern shift
• **Surface**: Fiber optic biosensor tips (SA, Ni-NTA, AHC)
• **Flow**: Dip-and-read (no microfluidics)
• **Best for**: High-throughput, crude samples, antibody screening

---

Troubleshooting: Why BLI works but SPR doesn't

| Cause | Mechanism | Solution | |-------|-----------|----------| | **Hydrophobic CDRs** | Adsorb to SPR gold/dextran surface | Add 0.05% Tween-20, use CM7 chip with longer dextran | | **Aggregation** | Mass transport artifacts in SPR fluidics | Filter sample (0.22μm), reduce ligand density | | **High instability** | Degrades during continuous flow | Shorter cycle time, add stabilizers (trehalose 5%) | | **Charge mismatch** | Nonspecific binding to charged dextran | Adjust buffer pH ±1 from pI, add BSA 1mg/mL | | **Slow dissociation** | Long regeneration needed (damages ligand) | Use BLI (disposable tips) |

Why SPR works but BLI doesn't

| Cause | Mechanism | Solution | |-------|-----------|----------| | **Small analyte** | BLI less sensitive for <10 kDa | Use SPR with appropriate chip | | **Weak affinity (KD >10μM)** | Fast dissociation in BLI dip | Increase analyte concentration | | **Low expression** | Not enough signal | Increase biosensor loading |

---

Mass transport considerations

Mass transport limitation occurs when analyte cannot diffuse to the surface fast enough to maintain equilibrium. This distorts kinetic parameters.

Symptoms

• Observed kon appears slower than true kon
• Linear association phase (instead of exponential)
• kon varies with ligand density
• Rmax varies with flow rate

When mass transport matters

• **High-affinity interactions** (kon >10^6 M^-1s^-1)
• **High ligand density** (>500 RU)
• **Slow flow rates** (<30 μL/min in SPR)
• **Large analytes** (slow diffusion)

Mitigation strategies

| Strategy | SPR | BLI | |----------|-----|-----| | Reduce ligand density | <200 RU for high-affinity | <0.5 nm shift loading | | Increase flow rate | 50-100 μL/min | Increase shake speed (1000 rpm) | | Use oriented immobilization | His-tag capture | Biotinylated ligand | | Include in fitting | Mass transport model (kt) | Usually less critical |

---

Nonspecific binding mitigation

Buffer additives (ranked by effectiveness)

| Additive | Concentration | Mechanism | Best For | |----------|---------------|-----------|----------| | BSA | 0.5-1 mg/mL | Blocks hydrophobic sites | General use | | Tween-20 | 0.02-0.05% | Prevents surface adsorption | Hydrophobic analytes | | Trehalose | 1-5% | Stabilizes + blocks | Unstable proteins | | Sucrose | 5% | BLI-specific blocker | BLI tips | | Carboxymethyl dextran | 1 mg/mL | Competitive blocking | SPR with charged proteins | | NaCl | 150-500 mM | Reduces ionic interactions | Charged proteins |

pH optimization

• Keep buffer pH at least 1 unit away from analyte pI
• pI near 7: Use pH 6.0 or 8.0 buffer
• Acidic proteins (pI <5): Use neutral or basic buffer
• Basic proteins (pI >9): Use slightly acidic buffer

Reference subtraction

**Always include**:

• Blank reference channel (no ligand)
• Buffer-only injections
• Non-specific binding controls

---

Regeneration conditions

SPR regeneration scouting (try in order)

| Condition | Targets | Caution | |-----------|---------|---------| | 10 mM Glycine pH 2.0-2.5 | Most protein-protein | May denature ligand | | 10 mM Glycine pH 1.5 | Strong interactions | Harsh, limit exposure | | 1-2 M NaCl | Ionic interactions | Mild, try first | | 10 mM NaOH | Very stable ligands | Can hydrolyze proteins | | 10 mM Glycine pH 9-10 | Acid-stable proteins | Can aggregate | | 10 mM EDTA | His-tag, metal-dependent | Strips Ni-NTA | | 4 M MgCl2 | Hydrophobic interactions | Check ligand stability |

Regeneration protocol

1. Start with mildest condition (high salt) 2. Test 30s contact time 3. Verify complete dissociation (return to baseline) 4. Verify retained ligand activity (repeat binding) 5. Use shortest effective contact time

BLI tips

• Tips are often disposable (no regeneration needed)
• For reuse: Same conditions as SPR, but shorter exposure
• Anti-His tips: 10 mM Glycine pH 1.5, 30s
• Streptavidin tips: Generally not regenerable

---

Common artifacts and solutions

Biphasic binding

**Symptoms**: Two-rate association or dissociation **Causes**:

• Sample heterogeneity (aggregates)
• Ligand heterogeneity (multiple conformations)
• Avidity effects (bivalent analyte)

**Solutions**:

• Filter/centrifuge sample
• Use monovalent Fab fragments
• Re